What's Happening With Palisade Bio Stock?
Portfolio Pulse from Henry Khederian
Palisade Bio Inc's shares are trading lower by 0.66% after the company announced a $2 million registered direct offering. The company plans to use the net proceeds for working capital and general corporate purposes. Ladenburg Thalmann & Co. Inc. is the exclusive placement agent for the offering.
September 11, 2023 | 1:46 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Palisade Bio's stock is trading lower following the announcement of a $2 million registered direct offering. The funds will be used for working capital and general corporate purposes.
The stock price of Palisade Bio is trading lower due to the announcement of a $2 million registered direct offering. This often leads to dilution of shares, which can negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100